分娩女性使用瑞芬太尼时呼吸生理变量报警分析
该研究对19例接受瑞芬太尼静脉自控镇痛的分娩女性进行呼吸生理数据二次分析,发现52.6%的产妇共发生62次呼吸暂停;呼吸频率低于8次/分和整合肺指数≤4的报警对呼吸暂停检测敏感性为100%,但所有变量的阳性预测值均较低,提示现有呼吸监测作为呼吸暂停早期预警的局限性。
要点
- 接受瑞芬太尼分娩镇痛的产妇中52.6%发生呼吸暂停,需加强呼吸监测。
- 呼吸频率<8次/分和整合肺指数≤4对呼吸暂停敏感性达100%。
- 血氧饱和度<92%报警遗漏大部分呼吸暂停,阳性预测值仅4.3%。
核心结论
- 多数接受瑞芬太尼静脉分娩镇痛的产妇发生呼吸暂停。
- EtCO2<15 mmHg、RR<8 bpm和IPI≤4报警可检测多数呼吸暂停,而SpO2<92%报警遗漏大部分呼吸暂停。
- 所有变量阳性预测率均低,显示所用呼吸监测作为该情境下呼吸暂停早期预警监测的局限性。
研究设计与样本
- 前瞻性IRB批准研究的二次分析,数据来自接受瑞芬太尼静脉自控bolus 20-60 μg每1-2分钟的分娩女性。
- 连续记录呼吸频率、呼气末CO2、脉搏血氧饱和度、心率和整合肺指数。
- 呼吸暂停定义为最大CO2<5 mmHg持续至少30秒。
主要发现
- 19例产妇中10例(52.6%)发生62次呼吸暂停,总剂量1725±1392 μg,给药时间160±132分钟。
- 共331次即时早期预警报警,其中271次(82%)持续≥10秒。
- 呼吸暂停检测敏感性:RR<8 bpm和IPI≤4均为100%(99% CI:90.3-100),EtCO2<15 mmHg为75.8%(99% CI:59.8-86.9),SpO2<92%为14.5%(99% CI:6.5-29.4)。
- 报警对呼吸暂停的阳性预测值:RR为35.8%(99% CI:27.1-45.6),EtCO2为28.9%(99% CI:20.8-38.7),SpO2为4.3%(99% CI:1.9-9.6),IPI为24.6%(99% CI:18.3-32.2)。
- RR、EtCO2、SpO2和IPI报警时间差异有统计学意义(Friedman's Q=33.53;P<.0001);EtCO2中位提前时间为-0.2(-12.2至0.7)秒,SpO2为40.0(40.0至40.0)秒。
关键数值与推荐
- 即时早期预警报警定义为变量值低于预设阈值持续15秒:RR<8 bpm、EtCO2<15 mmHg、SpO2<92%。
- 持续报警定义为上述值继续低于阈值≥10秒。
- IPI值范围1-10(10=健康,≤4=需立即关注,1=危急状态),由专有算法基于RR、EtCO2、SpO2和HR生成。
临床怎么用
- 瑞芬太尼分娩镇痛期间应警惕呼吸暂停,RR<8 bpm和IPI≤4可作为敏感检测指标。
- SpO2<92%报警可能遗漏多数呼吸暂停,不宜单独作为呼吸暂停早期预警。
- 所有变量阳性预测值低,需结合临床评估以减少误报。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Remifentanil may be used by laboring women for analgesia, despite controversy because of potential apneas. We evaluated candidate variables as early warning alerts for apnea, based on prevalence, positive predictive rate, sensitivity for apnea event detection, and early warning alert time intervals (lead time) for apnea. METHODS: We performed a secondary analysis of respiratory physiological data that had been collected during a prospective IRB-approved study of laboring women receiving IV patient-controlled boluses of remifentanil 20 to 60 μg every 1 to 2 minutes. Analyzed data included the respiratory rate (RR), end-tidal CO2 (EtCO2), pulse oximetry (SpO2), heart rate (HR), and the Integrated Pulmonary Index (IPI; Capnostream 20; Medtronic, Boulder, CO) that had been recorded continuously throughout labor. We defined immediate early warning alerts as any drop in a variable value below a prespecified threshold for 15 seconds: RR < 8 breaths per minute (bpm), EtCO2 < 15 mm Hg, and SpO2 < 92%. We defined alerts as "sustained" when the value remained below the threshold for ≥ 10 further seconds. The IPI value (1 to 10; 10 = healthy patient, ≤4 = immediate attention required, 1 = dire condition) was generated from a proprietary algorithm using RR, EtCO2, SpO2, and HR parameters. Apnea was defined as maximal CO2 < 5 mm Hg for at least 30 consecutive seconds. RESULTS: We counted 62 apneas, among 10 of 19 (52.6%) women who received remifentanil (total dose 1725 ± 1392 μg, administered over 160 ± 132 minutes). We counted 331 immediate early warning alerts for the variables; 271 (82%) alerts were sustained for ≥10 seconds. The positive predictive value of alerts for apnea was 35.8% (99% confidence interval [CI]: 27.1-45.6), 28.9% (99% CI: 20.8-38.7), 4.3% (99% CI: 1.9-9.6), and 24.6% (99% CI: 18.3-32.2) for RR, EtCO2, SpO2, and IPI, respectively. The sensitivity for apnea event detection was 100% (99% CI: 90.3-100) for RR (<8 bpm) and IPI (≤4); 75.8% (99% CI: 59.8-86.9) for EtCO2 <15 mm Hg; and 14.5% (99% CI: 6.5-29.4) for SpO2 <92%. We found a statistically significant difference in the timing of RR, EtCO2, SpO2, and IPI alerts for apnea; Friedman's Q = 33.53; P < .0001. The EtCO2 had a median (interquartile range) lead time of -0.2 (-12.2 to 0.7) seconds, and SpO2 had a median (interquartile range) lead time of 40.0 (40.0 to 40.0) seconds. CONCLUSIONS: The majority of women receiving IV remifentanil for labor analgesia experienced apneas. Alerts for EtCO2 (<15 mm Hg), RR (<8 bpm), and IPI (≤4) detected most apneas, whereas SpO2 alerts missed the majority of apneas. All variables had a low positive predictive rate, demonstrating the limitations of the respiratory monitors utilized as early warning surveillance for apneas in this setting.
引用
- Weiniger CF, Carvalho B, Stocki D, et al. Analysis of Physiological Respiratory Variable Alarm Alerts Among Laboring Women Receiving Remifentanil. Anesth Analg. 2017. PMID: 27870644. doi:10.1213/ANE.0000000000001644
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。